In 2016 NICE is due to commence the review of this guidance, to register as a stakeholder please contact us at firstname.lastname@example.org
This guidance on the Ambu aScope2 for use in difficult airways was developed using the NICE medical technologies guidance process. During this process, NICE became aware of the development of the Ambu aScope3 product which is described in the implementation products supporting the guidance.
NICE medical technologies guidance addresses specific technologies notified to NICE by manufacturers. The ‘case for adoption’ recommendations are based on the claimed advantages of introducing the specific technology compared with current management of the condition. This ‘case’ is reviewed against the evidence submitted and expert advice. If the case for adopting the technology is supported, then the technology has been found to offer advantages to patients and the NHS. The specific recommendations on individual technologies are not intended to limit use of other relevant technologies which may offer similar advantages.
NICE has said the Ambu aScope2 can be used if a hospital unit has no access to a multiple-use endoscope or if one is unavailable (for example, if it is being sterilised). It can also be used to help replace a tracheostomy tube, if the tube used for the tracheostomy moves out of position. A tracheostomy is where a cut is made in the throat to create a direct airway. Hospital teams may want to use the Ambu aScope2 because it may improve safety in hospital units that don’t have multiple-use endoscopes, or where one might not be available. It is also likely to save money in these situations.
Next review: July 2017
This guidance represents the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, healthcare professionals are expected to take this guidance fully into account. However, the guidance does not override the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or guardian or carer.
Commissioners and/or providers have a responsibility to implement the guidance, in their local context, in light of their duties to have due regard to the need to eliminate unlawful discrimination, advance equality of opportunity, and foster good relations. Nothing in this guidance should be interpreted in a way that would be inconsistent with compliance with those duties.
Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible.